Literature DB >> 8340501

Nonbullous pemphigoid: prodrome of bullous pemphigoid or a distinct pemphigoid variant?

R Strohal1, K Rappersberger, H Pehamberger, K Wolff.   

Abstract

We describe two patients with pruritic, mainly urticarial or eczematous lesions associated with peripheral blood eosinophilia. No vesicles or blisters developed in either patient throughout the course of the disease (29 and 38 months, respectively). To characterize the clinicopathologic features of these patients we performed histopathologic studies, direct and indirect immunofluorescence, immunoelectron microscopy (patient 2), and immunoprecipitation of both patients' serum. Histopathologic examination revealed a moderate eosinophilic infiltrate partly arranged along the basement membrane zone and focally invading the epidermis. Linear deposits of immunoglobulin and C3 along the dermoepidermal junction were localized within the lamina lucida and over the hemidesmosomal plaques. Immunoprecipitation revealed the presence of circulating autoantibodies against the 230 kd bullous pemphigoid antigen. These findings suggest that our patients had a distinct, nonbullous variant of the pemphigoid spectrum.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8340501     DOI: 10.1016/0190-9622(93)70179-w

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

1.  Photoletter to the editor: An eczema-like, pruritic, nonbullous form of bullous pemphigoid.

Authors:  Kui Young Park; Moo Yeol Hyun; In Kwon Yeo; Seong Jun Seo; Chang Kwun Hong
Journal:  J Dermatol Case Rep       Date:  2015-06-30

Review 2.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Assessment of the Prevalence of Mucosal Involvement in Bullous Pemphigoid.

Authors:  Khalaf Kridin; Reuven Bergman
Journal:  JAMA Dermatol       Date:  2019-02-01       Impact factor: 10.282

4.  Association of Bullous Pemphigoid With Dipeptidyl-Peptidase 4 Inhibitors in Patients With Diabetes: Estimating the Risk of the New Agents and Characterizing the Patients.

Authors:  Khalaf Kridin; Reuven Bergman
Journal:  JAMA Dermatol       Date:  2018-10-01       Impact factor: 10.282

Review 5.  Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

Review 6.  The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations.

Authors:  Khalaf Kridin; Ralf J Ludwig
Journal:  Front Med (Lausanne)       Date:  2018-08-20

7.  Bullous Pemphigoid Exacerbated by Radiation Therapy: An Atypical Presentation.

Authors:  Rachel Choi; Shawn Cowper; Melissa Young; Jonathan Leventhal
Journal:  Adv Radiat Oncol       Date:  2021-09-10

Review 8.  The significance of preclinical anti-BP180 autoantibodies.

Authors:  Yosuke Mai; Kentaro Izumi; Shoko Mai; Hideyuki Ujiie
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.